Exact sciences corporation (EXAS)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-106,751

-83,993

-215,912

-220,817

-218,664

-175,149

-142,939

-124,472

-118,875

-114,397

-129,803

-140,709

-154,684

-167,211

-170,032

-175,174

-169,475

-157,803

-150,256

-139,371

-119,742

-100,048

-79,790

-58,890

-51,767

-46,514

-48,316

-50,108

-52,630

-52,421

-48,337

-43,158

-34,947

-28,675

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and other amortization

43,843

34,212

27,945

25,135

22,638

20,544

18,414

16,624

15,606

14,572

13,579

12,776

12,083

11,309

10,425

9,512

8,486

7,600

6,858

5,743

4,641

3,710

2,706

2,116

1,760

1,418

1,295

1,214

1,097

985

815

683

546

411

0

0

0

Loss on disposal of property, plant and equipment

-1,584

-1,394

-380

-468

-337

-353

-1,506

-959

-1,032

-954

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-100

0

0

0

-

-

-

-

-

-

-

-

Unrealized loss on revaluation of marketable equity securities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax benefit

-186,507

-185,109

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

121,894

108,500

76,403

68,553

64,003

60,300

57,052

51,332

41,834

35,500

29,961

25,349

23,761

23,732

21,675

20,489

20,530

18,050

16,025

15,210

13,145

11,520

10,727

8,411

8,784

7,744

7,129

6,845

5,413

5,493

5,281

4,871

4,313

3,964

0

0

0

Loss on settlement of convertible notes

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of convertible note debt discount and issuance costs

47,730

42,256

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred financing costs and other liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of liabilities

-

-

-

-

-

-

-

-

5,786

1,620

1,499

1,337

1,182

1,013

887

777

723

573

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred license fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

294

6,958

5,922

4,886

4,144

-4,144

-4,144

-4,144

-4,144

-4,144

-4,143

-4,143

-4,143

0

0

0

Amortization of deferred financing costs

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium on short-term investments

-1,876

-3,102

-4,067

-4,704

-4,174

-3,516

-2,306

-1,361

-464

88

107

174

286

463

715

967

1,160

1,323

1,234

1,174

1,074

842

806

736

641

636

631

582

568

532

0

0

0

-

-

-

-

Warrant licensing expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

152

179

205

107

107

0

0

0

Amortization of acquired intangible assets

38,614

16,035

3,119

2,927

2,688

2,540

2,185

1,921

1,545

983

695

390

200

200

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

14,740

5,427

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Accrued interest

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-106

-100

-95

22

22

21

22

22

21

22

21

21

21

21

21

21

21

0

0

0

Accounts receivable, net

22,404

27,938

38,666

26,017

20,992

17,292

17,363

13,313

17,997

17,529

16,326

15,150

10,593

3,593

3,654

5,290

4,040

3,557

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

21,389

19,041

14,664

11,980

11,497

12,729

20,553

22,999

24,521

19,194

10,398

4,006

-298

156

1,634

2,129

2,734

2,660

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

0

0

3,478

-

2,332

-923

-779

-761

-552

2,686

3,040

3,057

3,058

-168

1,050

1,329

1,473

2,900

1,775

1,606

-348

-1,260

-851

-441

385

1,736

1,450

788

0

0

0

Accounts payable and accrued liabilities

-12,611

3,469

7,490

29,974

34,721

33,076

39,118

23,867

26,495

30,537

6,397

-898

-1,950

-2,598

832

1,790

840

661

-3,132

988

670

1,886

4,030

-727

-750

-2,891

-425

317

1,132

2,887

53

-319

129

-263

0

0

0

Other assets and liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

0

0

13,327

-

11,202

4,430

9,217

7,349

8,593

7,863

9,069

7,424

6,570

7,066

4,299

8,064

5,325

4,255

3,383

2,299

1,801

658

1,099

532

2,429

2,503

1,746

1,542

0

0

0

Other short-term liabilities

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term obligations

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease incentive obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-312

-297

-300

-285

-553

-497

-493

-490

-487

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-90,683

-115,010

-87,562

-62,535

-104,957

-69,325

-68,853

-70,250

-76,608

-71,724

-98,089

-117,605

-121,357

-130,066

-133,220

-145,331

-141,027

-134,017

-135,195

-119,228

-104,444

-81,458

-60,309

-46,949

-40,509

-40,282

-40,697

-43,264

-45,443

-44,522

-42,619

-39,493

-33,214

-27,464

0

0

0

Cash flows from investing activities:
Purchases of marketable securities

796,398

634,117

714,973

809,237

826,891

1,192,506

1,093,674

1,063,659

954,990

357,051

383,572

372,119

214,434

189,989

158,513

191,854

200,027

205,054

266,113

89,934

218,264

209,471

150,604

165,532

91,631

98,510

94,900

134,116

75,315

96,047

106,223

79,602

114,487

87,017

0

0

0

Maturities and sales of marketable securities

1,467,220

1,660,559

1,621,214

781,003

730,492

579,171

483,268

370,833

295,391

271,466

245,993

242,792

188,877

193,321

195,270

192,963

192,847

162,283

136,309

125,728

110,869

104,172

104,490

86,990

80,277

72,289

62,076

62,126

58,612

58,411

70,420

59,451

60,457

45,725

0

0

0

Purchases of property, plant and equipment

173,830

171,802

183,076

185,177

145,422

150,093

122,025

84,196

61,063

48,480

27,127

17,084

15,207

14,851

18,231

16,726

20,102

20,084

16,488

14,568

9,599

11,991

13,857

14,218

13,135

8,748

4,508

1,678

862

681

1,102

2,133

2,065

2,115

0

0

0

Business combination, net of cash acquired

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other investing activities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Internally developed software

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-485,718

-121,073

704,284

-232,146

-260,385

-781,914

-747,843

-795,451

-747,464

-160,805

-176,169

-154,853

-40,764

-11,519

16,626

-17,517

-29,182

-64,755

-146,292

21,226

-116,994

-117,290

-59,971

-92,760

-24,489

-34,969

-37,332

-73,668

-17,565

-38,317

-36,905

-22,284

-56,095

-43,407

0

0

0

Cash flows from financing activities:
Proceeds from issuance of convertible notes, net

1,125,488

729,477

729,476

729,484

954,875

896,430

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock options

9,437

8,787

6,649

5,989

8,895

6,636

8,129

9,976

6,447

5,103

5,712

3,634

3,170

3,411

1,336

938

1,150

1,248

3,177

3,306

2,938

2,640

553

1,048

1,339

1,341

1,510

1,010

836

2,388

2,219

2,324

2,313

685

0

0

0

Payments on settlement of convertible notes

150,055

493,356

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from construction loan

24

319

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on mortgage payable

0

-

-

-

0

-

0

0

175

-

172

170

169

166

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

360

449

361

356

351

347

342

337

333

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

992,535

253,181

255,911

274,005

501,831

934,142

927,506

910,892

933,390

260,956

261,604

403,850

149,342

149,586

148,729

178,189

181,717

181,765

285,121

111,091

244,321

244,028

138,399

138,899

74,751

74,757

75,079

132,424

58,769

60,403

87,189

29,539

29,528

27,900

0

0

0

Effects of exchange rate changes on cash and cash equivalents

-

-

-

-

-

36

58

64

171

143

46

5

-166

-215

-212

-96

-36

11

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

416,134

17,098

872,629

-20,604

136,505

82,939

110,868

45,255

109,489

28,570

-12,608

131,397

-12,945

7,786

31,923

15,245

11,472

-16,996

3,693

13,057

22,873

45,280

18,119

-810

9,753

-494

-2,950

15,492

-4,239

-22,436

7,665

-32,238

-59,781

-42,971

0

0

0

Supplemental disclosure of non-cash investing and financing activities:
Property, plant and equipment acquired but not paid

-18,223

10,265

24,671

32,833

63,058

33,452

30,602

31,734

20,556

8,818

4,036

1,705

396

655

-1,267

1,791

1,903

1,705

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain (loss) on available-for-sale investments, before tax

-2,496

1,322

1,391

4,550

3,074

-708

-1,150

-1,563

-2,076

-475

-173

-367

-248

230

-130

90

-51

-329

102

-140

-53

-240

-124

22

62

47

26

86

50

92

142

65

22

-15

0

0

0

Issuance of 136,559 and 86,532 shares of common stock to fund the Company’s 401(k) matching contribution for 2019 and 2018, respectively

12,007

7,409

7,409

7,409

7,412

4,303

4,303

4,303

4,300

3,008

3,008

3,008

3,013

2,151

2,152

2,152

2,147

836

835

835

835

456

456

456

456

354

354

354

354

274

274

274

274

169

0

0

0

Issuance of 2,158,991 shares of common stock upon settlement of convertible notes

42

182,477

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Retirement of equity component of convertible notes settled

-64,199

-300,768

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for business combinations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental Cash Flow Information [Abstract]
Interest paid

11,314

9,301

9,117

9,929

6,302

4,638

4,688

197

199

201

203

205

206

209

243

192

144

95

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-